These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4819220)

  • 1. A clinical trial of megestrol acetate in advanced breast cancer.
    Ansfield FJ; Davis HL; Ellerby RA; Ramirez G
    Cancer; 1974 Apr; 33(4):907-10. PubMed ID: 4819220
    [No Abstract]   [Full Text] [Related]  

  • 2. Further clinical studies with megestrol acetate in advanced breast cancer.
    Ansfield FJ; Davis HL; Ramirez G; Davis TE; Borden EC; Johnson RO; Bryan GT
    Cancer; 1976 Jul; 38(1):53-5. PubMed ID: 947534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of megestrol acetate in the treatment of cancer cachexia.
    Parnes H; Tait N; Aisner J
    Nutrition; 1989; 5(3):206-9. PubMed ID: 2520291
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy.
    Buzdar AU; Tashima CK; Blumenschein GR; Hortobagyi GN; Yap HY; Krutchik AN; Bodey GP; Livingston RB
    Cancer; 1978 Feb; 41(2):392-5. PubMed ID: 630529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.
    Carpenter JT; Peterson L
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):40-2. PubMed ID: 3975651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases.
    Alexieva-Figusch J; van Gilse HA; Hop WC; Phoa CH; Blonk-van der Wijst J; Treurniet RE
    Cancer; 1980 Dec; 46(11):2369-72. PubMed ID: 7438013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose megestrol acetate in the treatment of advanced breast cancer.
    Tchekmedyian NS; Tait N; Abrams J; Aisner J
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):44-9. PubMed ID: 3368800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential applications of high-dose megestrol acetate in breast cancer.
    Abrams JS; Gutheil J; Aisner J
    Oncology; 1992; 49 Suppl 2():12-7. PubMed ID: 1461620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
    Tchekmedyian NS; Tait N; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic breast cancer: preliminary results with oral hormonal therapy.
    Allegra JC; Bertino J; Bonomi P; Byrne P; Carpenter J; Catalano R; Creech R; Dana B; Durivage H; Einhorn L
    Semin Oncol; 1985 Dec; 12(4 Suppl 6):61-4. PubMed ID: 3909420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
    Cruz JM; Muss HB; Russell G
    Oncology; 1992; 49 Suppl 2():8-11. PubMed ID: 1461630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
    Aisner J; Tchekmedyian NS; Moody M; Tait N
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):48-55. PubMed ID: 3589708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
    J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
    Cruz JM; Muss HB; Brockschmidt JK; Evans GW
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
    Allegra JC
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.
    Alexieva-Figusch J; Blankenstein MA; Hop WC; Klijn JG; Lamberts SW; de Jong FH; Docter R; Adlercreutz H; van Gilse HA
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):33-40. PubMed ID: 6363095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of megestrol acetate for the treatment of advanced breast cancer.
    Sedlacek SM
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.